Forbes -- Pfizer Inc., the world’s biggest drugmaker, said Friday a late-stage trial of Sutent reveals that the kidney cancer treatment also helps slow the growth of rare pancreatic neuroendocrine tumors.
Forbes -- Pfizer Inc., the world’s biggest drugmaker, said Friday a late-stage trial of Sutent reveals that the kidney cancer treatment also helps slow the growth of rare pancreatic neuroendocrine tumors.
